TRANS-3-[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]CYCLOBUTANEMETHANOL, 95.0%, 100mg

(S)-5-(Aminomethyl)-3-(3-fluoro-4-morpholinophenyl)oxazolidin-2-one, 95.0%, 1g

tert-Butyl 2-oxo-5-oxa-8-azaspiro[3.5]nonane-8-carboxylate, 98%, 1g

3-Ethynyl-1H-indole, 95.0%, 5g

(S)-1-(3-((6-(6-METHOXY-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)-5,6,7,8-TETRAHYDROPYRIDO[4,3-D]PYRIMIDIN-4-YL)AMINO)PYRROLIDIN-1-YL)PROPAN-1-ONE, 95%, 10mg

tert-Butyl 2,6-diazaspiro[3.3]heptane-2-carboxylate oxalate, 95.0%, 250mg

1-Bromo-3-fluoro-2-methyl-5-nitrobenzene, 97%, 10g

(S)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic acid, 95.0%, 100mg

(S)-1-(4-(Trifluoromethyl)phenyl)ethanol, 95.0%, 1g

3-(4-Methylnaphthalen-1-yl)propanoic acid, 95.0%, 1g

Diethylenetriaminepentaacetic acid, min. 99%, for synthesis, 500 g, plastic packaging.

1-Bromo-5-fluoro-2-nitrobenzene, 97.0%, 25g

(4-BROMO-1,2-PHENYLENE)DIMETHANOL, 95.0%, 100g